Sanofi’s vaccines division -- Sanofi Pasteur -- has launched ShanIPV, an injectable inactivated polio vaccine (IPV) manufactured by its arm Shantha Biotechnics in Hyderabad.
ShanIPV is a ‘made in India’ vaccine, manufactured in Hyderabad through technology transfer from Sanofi Pasteur. It is currently approved for use in the Indian market.
Both Sanofi Pasteur and its affiliate Shantha will provide the majority of vaccine doses needed till the end of 2016. All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) will be delivered to India through UNICEF.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: